does medicare part d cover glp 1 drugs New GLP-1 coverage Access to GLP-1 weight management

Diabetes 41 , 467473 (2023)

Hendriks FK, Kooman JP, van Loon LJC

This dual action is likely why Mounjaro tends to yield better results than Wegovy

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial

GLP-1RA is safe for use in children and adolescents over the age of 10 years, and some formulations have been approved for pediatric T2DM or obesity

The weight loss achieved with GLP-1 therapy appears central to hepatic benefits, as weight reduction of 710% consistently improves NAFLD across multiple intervention studies